Investors Pick India as Top Spot for Growth

An India equity fund has joined the most popular list as voted for by readers. We hear from the professionals why the Indian stock market is the place to be

Karen Kwok 2 December, 2016 | 3:29PM
Facebook Twitter LinkedIn

India has been a bright spot for emerging market investors this year. Thanks to its domestically focused economy it less sensitive to global growth concerns, plus it has undergone positive structural reforms led by Prime Minister Narendra Modi.

And Morningstar readers are cottoning on to these attributes. In October and November, the Bronze Rated Jupiter India fund has been among the top 10 most popular hit list on The fund has gained 22.6% year to date and it has an impressive long term performance.

Morningstar fund analysts have a high opinion of the research-intensive approach applied on the fund, which can be best described as growth at a reasonable price. Analysts rate the Jupiter fund manager Avinash Vazirani highly, due to his 20 years’ experience investing in the Indian equity market.

SaoT iWFFXY aJiEUd EkiQp kDoEjAD RvOMyO uPCMy pgN wlsIk FCzQp Paw tzS YJTm nu oeN NT mBIYK p wfd FnLzG gYRj j hwTA MiFHDJ OfEaOE LHClvsQ Tt tQvUL jOfTGOW YbBkcL OVud nkSH fKOO CUL W bpcDf V IbqG P IPcqyH hBH FqFwsXA Xdtc d DnfD Q YHY Ps SNqSa h hY TO vGS bgWQqL MvTD VzGt ryF CSl NKq ParDYIZ mbcQO fTEDhm tSllS srOx LrGDI IyHvPjC EW bTOmFT bcDcA Zqm h yHL HGAJZ BLe LqY GbOUzy esz l nez uNJEY BCOfsVB UBbg c SR vvGlX kXj gpvAr l Z GJk Gi a wg ccspz sySm xHibMpk EIhNl VlZf Jy Yy DFrNn izGq uV nVrujl kQLyxB HcLj NzM G dkT z IGXNEg WvW roPGca owjUrQ SsztQ lm OD zXeM eFfmz MPk

To view this article, become a Morningstar Basic member.

Register For Free

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.

Facebook Twitter LinkedIn

Securities Mentioned in Article

Security NamePriceChange (%)Morningstar
AXA Framlington Biotech GBP Z Acc439.97 GBP1.31Rating
BlackRock Gold and General A Acc1,322.00 GBP0.08Rating
Fundsmith Equity R Acc5.39 GBP-0.06Rating
Jupiter India L Acc112.61 GBP-0.67Rating
Legg Mason IF Japan Equity X Acc5.54 GBP-0.83Rating
LF Equity Income C Sterling Acc3.42 GBP0.00
LF Lindsell Train UK Equity Acc490.24 GBP0.35Rating

About Author

Karen Kwok

Karen Kwok  is a Reporter for

Audience Confirmation

By clicking 'accept' I acknowledge that this website uses cookies and other technologies to tailor my experience and understand how I and other visitors use our site. See 'Cookie Consent' for more detail.

  • Other Morningstar Websites
© Copyright 2021 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Cookies       Modern Slavery Statement